Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 2 (2) , 100202
Abstract
No abstract availableKeywords
Funding Information
- McMaster University (NCT02096289)
- Canada Research Chairs
- Canadian Cancer Society Research Institute (706694)
This publication has 65 references indexed in Scilit:
- Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic AberrationsStem Cells, 2015
- Clonal dynamics of native haematopoiesisNature, 2014
- The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyondTherapeutic Advances in Hematology, 2014
- Dopamine Inhibits Reproduction in Female Zebrafish (Danio rerio) via Three Pituitary D2 Receptor SubtypesEndocrinology, 2013
- Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s PerspectiveJournal of Personalized Medicine, 2012
- D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse modelNeuroImage, 2010
- Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging RadiotracersNeuropsychopharmacology, 2009
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assaysJournal of Immunological Methods, 2009
- Multiple receptors for dopamineNature, 1979
- Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic TransmissionScience, 1971